Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Sarepta TherapeuticsGenmab A/SArray BiopharmaMylanMerck KGaA
SymbolNASDAQ:SRPTOTCMKTS:GNMSFNASDAQ:ARRYNASDAQ:MYLOTCMKTS:MKGAF
Price Information
Current Price$95.07$203.35$47.85$19.04$105.15
52 Week RangeBuyBuyHoldBuyN/A
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyN/A
Consensus Price Target$186.2353N/A$38.4722$30.2368N/A
% Upside from Price Target95.89% upsideN/A-19.60% downside58.81% upsideN/A
Trade Information
Market Cap$7.41 billion$12.46 billion$10.68 billion$9.90 billion$13.59 billion
Beta2.010.171.71.770.67
Average Volume1,341,7187414,985,5776,921,389953
Sales & Book Value
Annual Revenue$301.03 million$359.31 million$173.77 million$11.43 billion$17.52 billion
Price / Sales23.4834.6861.440.860.78
CashflowN/A$2.7398 per shareN/A$8.6154 per share$36.5104 per share
Price / CashN/A74.22N/A2.212.88
Book Value$14.79 per share$20.36 per share$1.04 per share$23.07 per share$157.47 per share
Price / Book6.439.9946.010.830.67
Profitability
Net Income$-361,920,000.00$167.62 million$-147,340,000.00$352.50 million$3.98 billion
EPS($5.46)N/A($0.73)$4.58N/A
Trailing P/E RatioN/A63.35N/A4.1618.63
Forward P/E RatioN/A45.39N/A4.21
P/E GrowthN/AN/AN/A$0.91N/A
Net Margins-165.52%N/A-52.64%0.30%21.17%
Return on Equity (ROE)-55.37%N/A-48.51%18.93%12.88%
Return on Assets (ROA)-34.90%N/A-24.15%7.00%5.70%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.44%0.02%0.45%1.15%0.29%
Current Ratio8.81%14.89%5.70%1.37%0.94%
Quick Ratio7.84%14.89%5.65%0.77%0.68%
Ownership Information
Institutional Ownership Percentage93.59%0.08%N/A83.27%N/A
Insider Ownership Percentage6.60%N/A2.10%0.81%N/A
Miscellaneous
Employees49937729835,00051,749
Shares Outstanding74.34 million61.28 million223.13 million515.87 million129.24 million
Next Earnings Date10/23/2019 (Estimated)11/13/2019 (Estimated)N/A11/4/2019 (Estimated)8/22/2019 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableNot Optionable
 Sarepta TherapeuticsGenmab A/SArray BiopharmaMylanMerck KGaA

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel